Share on StockTwits

CareFusion (NYSE:CFN) Insider Thomas J. Leonard sold 19,721 shares of the company’s stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $45.00, for a total transaction of $887,445.00. Following the sale, the insider now directly owns 33,303 shares of the company’s stock, valued at approximately $1,498,635. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of CareFusion (NYSE:CFN) traded up 0.51% on Thursday, hitting $45.63. 625,342 shares of the company’s stock traded hands. CareFusion has a 52-week low of $35.01 and a 52-week high of $45.52. The stock’s 50-day moving average is $43.32 and its 200-day moving average is $40.87. The company has a market cap of $9.460 billion and a price-to-earnings ratio of 25.39.

CareFusion (NYSE:CFN) last announced its earnings results on Monday, May 5th. The company reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.62 by $0.02. The company had revenue of $968.00 million for the quarter, compared to the consensus estimate of $986.67 million. During the same quarter in the previous year, the company posted $0.59 earnings per share. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. Analysts expect that CareFusion will post $2.31 EPS for the current fiscal year.

A number of analysts have recently weighed in on CFN shares. Analysts at Topeka Capital Markets initiated coverage on shares of CareFusion in a research note on Thursday, June 12th. They set a “hold” rating and a $44.00 price target on the stock. Separately, analysts at Raymond James raised their price target on shares of CareFusion from $48.00 to $50.00 in a research note on Monday, May 19th. They now have a “strong-buy” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of CareFusion in a research note on Wednesday, May 7th. They now have a $41.00 price target on the stock. Five analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $42.45.

CareFusion Corporation (NYSE:CFN) is a global medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.